122 related articles for article (PubMed ID: 22416214)
1. Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells.
Yi H; Cho HJ; Cho SM; Jo K; Park JA; Lee SH; Chang BJ; Kim JS; Shin HC
Korean J Physiol Pharmacol; 2012 Feb; 16(1):11-6. PubMed ID: 22416214
[TBL] [Abstract][Full Text] [Related]
2. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC
Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer.
Xu J; Su Q; Gao M; Liang Q; Li J; Chen X
Onco Targets Ther; 2019; 12():10477-10486. PubMed ID: 31819528
[TBL] [Abstract][Full Text] [Related]
4. Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines.
Fakiruddin KS; Lim MN; Nordin N; Rosli R; Abdullah S
Biology (Basel); 2021 Oct; 10(11):. PubMed ID: 34827096
[TBL] [Abstract][Full Text] [Related]
5. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression.
Oliver JA; Ortiz R; Jimenez-Luna C; Cabeza L; Perazzoli G; Caba O; Mesas C; Melguizo C; Prados J
J Biosci; 2020; 45():. PubMed ID: 33097678
[TBL] [Abstract][Full Text] [Related]
6. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
Kim D; Park M; Jang H; Hyun H; Lim W
Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
Lee MR; Ji SY; Mia-Jan K; Cho MY
Biochem Biophys Res Commun; 2015 Jul; 463(3):229-34. PubMed ID: 26002465
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
14. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
Li F; Zeng H; Ying K
Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
[TBL] [Abstract][Full Text] [Related]
15. Functional expression and characterization in Xenopus laevis oocytes of the ABCG2 transporter derived from A549 human lung adenocarcinoma cells.
Lee DG; Cho HJ; Yi H; Cho SM; Jo K; Park JA; Lee BH; Hwang SH; Jeong SM; Nah SY; Shin HC
Oncol Rep; 2012 Feb; 27(2):499-503. PubMed ID: 21971989
[TBL] [Abstract][Full Text] [Related]
16. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells.
Campard D; Vasse M; Rose-John S; Poyer F; Lamacz M; Vannier JP
Stem Cells; 2006 May; 24(5):1302-14. PubMed ID: 16357344
[TBL] [Abstract][Full Text] [Related]
17. Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation.
Ramović Hamzagić A; Cvetković D; Gazdić Janković M; Milivojević Dimitrijević N; Nikolić D; Živanović M; Kastratović N; Petrović I; Nikolić S; Jovanović M; Šeklić D; Filipović N; Ljujić B
Curr Oncol; 2024 Feb; 31(3):1221-1234. PubMed ID: 38534924
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
19. Co-detection of ALDH1A1, ABCG2, ALCAM and CD133 in three A549 subpopulations at the single cell level by one-step digital RT-PCR.
Xu Y; Hu J; Zhu Q; Song Q; Mu Y
Integr Biol (Camb); 2018 Jun; 10(6):364-369. PubMed ID: 29808880
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]